BiotechTube
Home/Vertero Therapeutics/Jeffrey Kasten
JK

Jeffrey Kasten

Chief Business Officer

Vertero Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesParkinson's Disease

Vertero Therapeutics Pipeline

DrugIndicationPhase
VT-5006Parkinson's DiseasePre-clinical

Leadership Team at Vertero Therapeutics

AS
A. Stewart Campbell, PhD
Chief Executive Officer
BS
Becca Senter, PhD
Chief Scientific Officer
View full Vertero Therapeutics profile